The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(3-Methoxy-phenylsulfanyl)-9-pent-4-ynyl-9H-purin-6-ylamine ID: ALA191241
PubChem CID: 11186831
Max Phase: Preclinical
Molecular Formula: C17H17N5OS
Molecular Weight: 339.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C#CCCCn1c(Sc2cccc(OC)c2)nc2c(N)ncnc21
Standard InChI: InChI=1S/C17H17N5OS/c1-3-4-5-9-22-16-14(15(18)19-11-20-16)21-17(22)24-13-8-6-7-12(10-13)23-2/h1,6-8,10-11H,4-5,9H2,2H3,(H2,18,19,20)
Standard InChI Key: VQKBRDXFGLLDPX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
2.1250 1.4083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6375 0.7375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6375 2.0833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8542 1.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8542 0.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1375 2.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1375 0.5750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9500 1.4083 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.5750 1.8125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0417 -2.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4917 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5750 0.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3625 0.6958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1875 0.6958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8917 -0.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1292 3.0583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5917 -0.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4167 -0.0250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5917 -1.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3542 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -0.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1792 -0.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3417 -0.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 0.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 3 1 0
5 2 1 0
6 4 2 0
7 5 2 0
8 1 1 0
9 6 1 0
10 19 1 0
11 10 3 0
12 7 1 0
13 8 1 0
14 13 1 0
15 2 1 0
16 6 1 0
17 14 2 0
18 17 1 0
19 23 1 0
20 21 1 0
21 13 2 0
22 20 2 0
23 15 1 0
24 18 1 0
4 5 1 0
9 12 2 0
22 17 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 339.42Molecular Weight (Monoisotopic): 339.1154AlogP: 2.98#Rotatable Bonds: 6Polar Surface Area: 78.85Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.51CX LogP: 3.37CX LogD: 3.37Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.55Np Likeness Score: -1.19
References 1. Llauger L, He H, Kim J, Aguirre J, Rosen N, Peters U, Davies P, Chiosis G.. (2005) Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90., 48 (8): [PMID:15828828 ] [10.1021/jm049012b ]